Member Info for stt1

The King's speech: focus on health

Waiting times and Mental Health Act priorities

https://www.covermagazine.co.uk/news/4336654/kings-speech-focus-health

Lets see if Hallsworthy distracts away from the other questions as well.

Company newsflow - bear points/red flags.

1) CEO has > 7m options, awarded only last year, back dated a year!! and vesting from few months time. I see that as a red flag. It's an incentive to talk up the company, as confirmed by the company. If company is talked up then some, including IIs, will buy in! What's you opinion?

"The LTIP has been designed to reward, incentivise and retainMr Khan to deliver sustainable growth for shareholders. The deemed date of award is 24 February 2022, which is the date Mr Khan was appointed CEO. Under the LTIP,Mr Khan has been awarded 7,227,273 nominal cost long term incentive options ("LTIP Options " ) over ordinary shares of £0.001 each in the

Company.

Vesting of the LTIP Options is conditional upon a three-year total shareholder return ("TSR") performance against an initial 11p reference price. A portion of the LTIP Options will vest on the third anniversary of the date of award subject to the achievement of a minimum 10% CAGR TSR performance increasing on a straight-line basis to vesting in full subject to the achievement of a 22.5% CAGR TSR performance.

The award of the LTIP Options is also subject to continued employment, malus and clawback provisions and will vest in full on a takeover of the Company."

https://polaris.brighterir.com/public/hvivo/news/rns/story/x21q5mw/export

2) Chairman dumps majority of his holding in a discounted secondary placing at 28p:

I see the Chairman dumping majority of his holding in a discounted placing as a red flag. What do you think?

Placing news - only 25% will be sold

https://polaris.brighterir.com/public/hvivo/news/rns/story/xlj8m3r/export

Yet, Chairman dumped majority of his holding:

I see that as a red flag as the Chairman knows the company better than any BB poster or II.

https://polaris.brighterir.com/public/hvivo/news/rns/story/xe1g9jw/export

3) Lack of revenue growth, as evidenced by the company results/expectations:

I see that as a bear point. What do you think?

Fy2022: £48.5m (+30%)

Fy2023: £56m (+15.5%)

Fy2024: £62m(+10.7%)

"Full year revenue of £56.0 million, an increase of 15.5% (2022: £48.5 million)

Revenue guidance of £62 million for 2024"

https://polaris.brighterir.com/public/hvivo/news/rns/story/xopzn1r/export

Hallsworthy,

There you go, distracting away because you can't answer.

Says it all, you're all mouth.

If there's huge demand what's stopping other pharmas from setting up a rival business? A few million to setup a rival facility is peanuts to large pharmas.

HVO's clients largely paid for the new facility, despite the company claiming £37m cash. Why didn't HVO use their own cash? What's in it for those clients who paid to setup the new facility?

What's stopping pharmas taking over HVO and setting up a rival business and cutting out competition?

No one can answer because the reply wouldn't suit the agenda.

Skywalker

"Nice to see lots of articles coming out again. Seems the writers really love hVIVO."

Exactly as I predicted, the company will be talked up again because the CEO has huge options, awarded last year (back dated a year!!!) and due to exercisable from few months time..

"The LTIP has been designed to reward, incentivise and retainMr Khan to deliver sustainable growth for shareholders. The deemed date of award is 24 February 2022, which is the date Mr Khan was appointed CEO. Under the LTIP,Mr Khan has been awarded 7,227,273 nominal cost

long term incentive options ("LTIP Options " ) over ordinary shares of £0.001 each in the Company.

Vesting of the LTIP Options is conditional upon a three-year total shareholder return ("TSR") performance against an initial 11p reference price. A portion of the LTIP Options will vest on the third anniversary of the date of award subject to the achievement of a minimum 10% CAGR TSR performance increasing on a straight-line basis to vesting in full subject to the achievement of a 22.5% CAGR TSR performance"

https://polaris.brighterir.com/public/hvivo/news/rns/story/x21q5mw/export

Hallsworthy,

"still don't know the answer to why a pharma didn't just buy HVO and be done. It shows a shocking lack of understanding of even the basics"

If it's that basic and simple, why not you tell readers the reason then?

Or you could divert away like you normally do.

S740

"Plus, the 70 years of data that HVO own is another huge barrier to anybody else starting in competition."

Pharmas could have setup a subsidiary, bought HVO (£100m when they were at that price) and owned 100%. Instead of buying HVO, they spent millions to pay for a new facility. Really?

The risk is entirely HVO's. The benefit is entirely Pharmas.

Ricky

"Clearly Pharma want to stick at what they do best and contract in CRO services as and when needed"

As and when. Pharmas aren't charities. They didn't spend millions of pounds (peanuts for them) to pay for a new facility to help HVO. They did so because it's to their benefit.

Look at Ted's history. Ted made an interesting comment on 3rd June

"Posters who suddenly appear on chat boards spouting doom and gloom want the share price to go down.

Sometimes this is because of a short position (very unlikely here) but most often it is because they want a lower entry point."

even more interesting was the next para:

"If they are not total idiots, they will try and time their efforts to coincide with a natural retrace / profit taking."

https://www.lse.co.uk/profiles/fathertedcrilly/

Not great timing either.

Do you suppose Ted is practising what he preaches, deramping so to get a lower entry point but thinks himself an total idiot for not timing it right? lol

Coincidence? - Ted also ramps HVO, same as 1gw_, Hallsworthy, moniman etc. who also deramp TLY.

The new facility was largely paid for by clients. Pharmas can be multi-billion pound companies. They obviously not charities.

Why did clients pay for setting up the new facility?

Who saves the money???? Pharmas, not HVO.

There's your answer as to why clients largely paid for the new facility.

They spent a few million to save huge amounts.

HVO make a few quid and have to carry out all the planning, recruiting and take all the risks.

If there is demand then there's nothing stopping pharmas from setting up rival facilities. Why don't they?

Ricky,

"Your previous argument of slow growth and suspect business model have been trashed. "

Has it? Read the TU and company newsflow.

Order book down. Revenue growth has slowed significantly. It's in the company newslow.

The CEO has >7m options which were awarded only last year (backdated by a year!!) and are exercisable from Feb 2025, so in a few months time.

The CEO has the incentive to talk up the company.

Why have huge options awarded to one director and back date them so that they are exercisable sooner? The Company then goes on a promotional drive over the past year.

Do you think it's a coincidence?

Read the TU, Media/analyst are welcome to attend the in-person event, so the company are talking it up.

"Analysts, institutional investors and media are welcome to attend the in-person event. "

I believe the business model is questionable.

Dustofnations,

The facts are there, regardless of how you want to spin them.

Obviously you're backing your conviction, loading up at 29p and not selling a single share for 2 years?

FatherTed,

That's rubbish.

As previously proved by me on several occassions. NHS England is independent of the govn, whoever it is.

The govn provides the funding and plans. How that funding is allocated is up to NHS England and ICBs.

"Resource allocation and oversight was delegated to NHS England, an arms-length body, by the Health and Social Care Act 2012. NHS England commissions primary care services (including GPs) and some specialist services, and allocates funding to 211[19] geographically based clinical commissioning groups (CCGs) across England. The CCGs commission most services in their areas, including hospital and community-based healthcare.

A number of types of organisation are commissioned to provide NHS services, including NHS trusts and private sector companies. Many NHS trusts have become NHS foundation trusts, giving them an independent legal status and greater financial freedoms. The following types of NHS trusts and foundation trusts provide NHS services in specific areas"

https://en.wikipedia.org/wiki/National_Health_Service_(England)

Which red flags have disappeared?

The Chairman dumped majority of his holding in a discounted secondary placing at 28p months ago. What's the current sp? around 28p.

The CEO still has huge >7m options, awarded only last year and exercisable from only a few months time. His options give him the incentive to talk up the company, don't they?

Others:

Growth has slowed significantly. Can you prove where's all the contracts?

Cash: Lack of decent dividends, new facility largely paid for by clients. Why, given they have £37m?

Company newsflow, all as expected.

;-)

There's nothing in today's update about dividends.

Given they have £37m cash, why did they need the new facility largely paid for by clients???? Why haven't they announced a decent dividend?

The Chairman dumped majority of his holding in a discounted secondary placing, so he's already taken off £millions, many months ago.

As predicted, the contracted order book has fallen.

Lack of contracts. As per my assertion, where's the significant growth?

What's the revenue expectation for fy2025? They would have visibility into 2025, wouldn't they?

"Weighted contracted orderbook of£71 million as at30 June 2024 (30 June 2023: £78 million), post-delivery of a record £35.6 million in revenues in H1 2024"

Was £80m at end of fy2023

As they said last year, the contracted order book underpins visibility into 2024, so why not mention it this year?

"Weighted contracted orderbook of £78 million as at 30 June 2023 (30 June 2022: c.£70 million) underpins venue visibility"

"Growing orderbook

As at 30 June 2023, the Group's weighted contracted orderbook increased to£78 million (H1 2022: £70 million), an increase of 11%, underlining the continued growth in demand for human challenge trials from the global biopharma industry. Importantly, the orderbook is diversified across multiple clients, challenge agents and geographies, which provides a strong foundation for long term revenue growth."

https://polaris.brighterir.com/public/hvivo/news/rns/story/rno86jw/export

We should know if cash at H1 end is lower than fy2023, as per my prediction made months ago.

If cash at H1 end is lower than fy2023 then I'd expect to see posters suggesting that it was obvious. If cash is higher then I'd expect to see the usual suspects shouting that I've got it wrong.

Obviously the pump and dump gang will pick the best metric for pulling the wool over reader's eyes, whilst they dump their shares....be it 'new facility is needed for growth', cash is great, institutions are buying so they must know better etc etc

Hallsworthy

"but the institutions buying now are doing so with a view to the year ahead and clearly see value"

What about all the selling?

I believe the chairman knows the business better than the IIs.

Do you?

The Chairman dumped majority of his holding in a discounted placing at 28p.

If you believe IIs clearly see value then why are you deramping TLY when IIs are buying there and c40% hold TLY??

Given the CEO has huge >7m options, awarded last year and exercisable in few months time, I think there will be a lot of talking up in the presentation.

Contract extensions for Elective Care & Urgent Care value around £11m to be recognised this fy.

Totally secures multiple contracts as commissioners tackle new targets

Contracts totalling c. £11 million all to be recognised during current financial year

Readers should read 1gw_'s posting history. You'll see exactly why he's here -

He hardly posts (as 1gw_), goes months without posting and soon as there's interest in TLY, he's deramping again.

https://www.lse.co.uk/profiles/1gw_/?page=1

Look at the posting history, he portray's himself as a well researched sensible poster. Look at his ramping posts on Byot/Trmr, all on page 1 of his history.

Why then, do virtually all his shares crash?

Despite his ramping..

Byot crashed 99.9% from peak to delisting.

Trmr, crashed 80% from peak.

https://www.lse.co.uk/profiles/1gw_/?page=1

Is it a coincidence posters from shares 1gw_ ramps and I post company newsflow on then come on here to deramp TLY?

Byot (crashed 99.9%)Trmr, I posted company newsflow and warned of the red flags.

Read the thread titled "Fantastic TU and interview" or "Sttsbumbag"

https://www.lse.co.uk/ShareChat.html?ShareTicker=BYOT&share=BYOT.L&page=4

Or

Trmr, thread "STiT scaremongering"

https://www.lse.co.uk/ShareChat.html?ShareTicker=TRMR&share=TRMR.L&page=21